4Dmedical (ASX:4DX) announced financial results for the quarter ended 30 September 2022.

PACT Act signed into law by President Biden, heralding a USD $280 billion expansion of healthcare benefits for millions of Veterans exposed to toxic burn pits.

Vanderbilt ?burn pit? trial demonstrates XV Technology can detect the presence of constrictive bronchiolitis.

American Medical Association accepts XV LVAS application to establish a new CPT code.

Commercial rollout expands to include Hobart and Launceston during the quarter, bringing the total number of sites to nine.

4DMedical releases CT LVAS in Australia and expects accelerated rollout.

Strong cash balance of $42.8 million as at 30 September 2022.

Following the announcement the company?s share price fell 4.477%.